Prentiss Smith & Co’s Sanofi SNY Stock Holding History

Prentiss Smith & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100	Closed	-$4K	–	202
2018 Q3	$4K	Hold	100	–	–	﹤0.01%	241
2018 Q2	$4K	Hold	100	–	–	﹤0.01%	245
2018 Q1	$4K	Hold	100	–	–	﹤0.01%	252
2017 Q4	$4K	Buy	+100	New	+$4.61K	﹤0.01%	265
2016 Q4	–	Sell	-179,328	Closed	-$6.85M	–	274
2016 Q3	$6.85M	Sell	179,328 -783	-0.4%	-$31.4K	3.83%	11
2016 Q2	$7.54M	Buy	180,111 +25,027	+16%	+$1.03M	4.25%	9
2016 Q1	$6.23M	Buy	155,084 +596	+0.4%	+$23.9K	3.59%	10
2015 Q4	$6.59M	Buy	154,488 +859	+0.6%	+$39.5K	3.49%	10
2015 Q3	$7.29M	Sell	153,629 -2,237	-1%	-$114K	4.04%	9
2015 Q2	$7.72M	Sell	155,866 -2,617	-2%	-$133K	3.79%	8
2015 Q1	$7.83M	Buy	+158,483	New	+$7.58M	3.74%	9

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Prentiss Smith & Co's SNY Position: Q4 2018 in Review

Prentiss Smith & Co sold out of Sanofi (SNY) in Q4 2018, closing a stake of 100 shares — an estimated $4K sold.

Prentiss Smith & Co first reported a position in SNY in Q1 2015 and held it in 11 quarters. The position peaked at $7.83M in Q1 2015. 501 funds tracked by Wall St. Rank hold SNY as of Q4 2018.

Prentiss Smith & Co reported no remaining Sanofi position as of Q4 2018 after selling out during the quarter.
Prentiss Smith & Co sold 100 Sanofi shares in Q4 2018, an estimated $4K.
Prentiss Smith & Co first reported a position in Sanofi in Q1 2015 and held it in 11 quarters.
Prentiss Smith & Co's Sanofi position peaked at $7.83M in Q1 2015.
501 funds tracked by Wall St. Rank held Sanofi as of Q4 2018.

Based on Prentiss Smith & Co's 13F filing for Q4 2018, filed 15 Jan 2019.